How to Maximize the Value Behind a BioCompute Object Based Approach to Handling Data & Pipeline
BioCompute is shorthand for the IEEE 2791-2020 standard for Bioinformatics Analyses Generated by High-Throughput Sequencing (HTS) to facilitate communication. This pipeline documentation approach has been adopted by several FDA centers. The goal is to ease the communication burdens between research centers, organizations, and industries. This presentation explores the value behind a BioCompute Object based approach to handling data and pipelines, and demonstrates the DNAnexus BCOnexus editor tool for editing, merging, and examining BCOs.
IN THIS WEBINAR YOU WILL LEARN:
An overview of BioCompute Objects (BCOs) - what they are, how they're useful, where they are accepted when working with the FDA
Using DNAnexus's BCOnexus tool to easily manipulate, merge, and edit BCOs
Future BCO projects, growth, and expansion within both government and industry settings
Sam Westreich is a Program Director at DNAnexus, covering the precisionFDA platform and related government contracts. Prior to joining DNAnexus, Sam earned his PhD at the University of California, Davis, focusing on building bioinformatics pipelines for analyzing metatranscriptomes of the gut microbiome. Sam has technical expertise in metagenomics, 16S rRNA sequencing, and study of the microbiome. He currently focuses on guiding the development and roadmap of the precisionFDA platform, working closely with government scientists, senior stakeholders, and other users from various industry groups who bring data, develop tools, and organize challenges on the precisionFDA platform.
Tianyi Wang, an MS-trained Bioinformatics specialist, holds the position of Outreach Lead for the BioCompute project at The George Washington University. As a Senior Research Assistant under the guidance of Dr. Raja Mazumder and other faculty, she manages research portfolios, develops bioinformatics research, and coordinates various projects, with a strong focus on the project's front-end interface.
